54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 30
15:42 UTC
|
META
Meta Platforms
|
◎ Target | John Blackledge ★★★☆☆ #1192 | Buy | $800.00→ $750.00-6.2% |
|
Jul 30
15:42 UTC
|
META
Meta Platforms
|
◎ Target | Andrew Boone ★☆☆☆☆ #2924 | Market Outperform | $800.00→ $770.00-3.8% |
|
Jul 30
15:42 UTC
|
MBLY
Mobileye Global
|
◎ Target | Ivan Feinseth ★★☆☆☆ #2680 | Buy | $25.00→ $18.00-28.0% |
|
Jul 30
15:42 UTC
|
KO
CocaCola
|
◎ Target | Taylor Conrad ★★★★☆ #425 | Buy | $91.00→ $97.00+6.6% |
|
Jul 30
15:42 UTC
|
IEX
IDEX
|
◎ Target | Joe Giordano not yet tracked | Buy | $260.00→ $275.00+5.8% |
|
Jul 30
15:42 UTC
|
GKOS
Glaukos
|
◎ Target | Richard Newitter ★★★★☆ #460 | Buy | $180.00→ $215.00+19.4% |
|
Jul 30
15:42 UTC
|
GKOS
Glaukos
|
◎ Target | Larry Biegelsen ★★★★☆ #858 | Overweight | $138.00→ $178.00+29.0% |
|
Jul 30
15:42 UTC
|
GEF
Greif
|
◎ Target | Gabe Hajde not yet tracked | Equal Weight | $74.00→ $90.00+21.6% |
|
Jul 30
15:42 UTC
|
FTRE
Fortrea
|
◎ Target | Jailendra Singh ★★★★★ #174 | Buy | $19.00→ $26.00+36.8% |
|
Jul 30
15:42 UTC
|
FICO
Fair Isaac
|
◎ Target | Jason Haas not yet tracked | Overweight | $1,400.00→ $1,450.00+3.6% |
|
Jul 30
15:42 UTC
|
EXP
Eagle Materials
|
◎ Target | Trey Grooms ★★★☆☆ #1700 | Equal Weight | $225.00→ $230.00+2.2% |
|
Jul 30
15:42 UTC
|
EXP
Eagle Materials
|
◎ Target | Timna Tanners ★★★☆☆ #2144 | Overweight | $240.00→ $231.00-3.8% |
|
Jul 30
15:42 UTC
|
EXE
Expand Energy
|
◎ Target | Gabe Daoud not yet tracked | Buy | $117.00→ $121.00+3.4% |
|
Jul 30
15:42 UTC
|
EFOR
ASGN
|
◎ Target | Jason Haas not yet tracked | Equal Weight | $33.00→ $26.00-21.2% |
|
Jul 30
15:42 UTC
|
DLR
Digital Realty Trust
|
◎ Target | Matthew Niknam ★★★☆☆ #1422 | Buy | $225.00→ $220.00-2.2% |
|
Jul 30
15:42 UTC
|
CTSH
Cognizant Technology Solutions
|
◎ Target | Jason Kupferberg ★★★★☆ #868 | Overweight | $61.00→ $67.00+9.8% |
|
Jul 30
15:42 UTC
|
CSTM
Constellium
|
◎ Target | Timna Tanners ★★★☆☆ #2144 | Overweight | $37.00→ $39.00+5.4% |
|
Jul 30
15:42 UTC
|
CLH
Clean Harbors
|
◎ Target | Tobey Sommer ★★★★★ #212 | Buy | $350.00→ $365.00+4.3% |
|
Jul 30
15:42 UTC
|
CHRW
C.H. Robinson Worldwide
|
◎ Target | Bascome Majors ★★★☆☆ #1992 | Overweight | $225.00→ $215.00-4.4% |
|
Jul 30
15:42 UTC
|
CAKE
Cheesecake Factory
|
◎ Target | Christine Dooley ★★★★☆ #557 | Buy | $72.00→ $110.00+52.8% |
|
Jul 30
15:42 UTC
|
BX
Blackstone
|
◎ Target | Stephen Biggar ★★★★☆ #467 | Buy | $146.00→ $150.00+2.7% |
|
Jul 30
15:42 UTC
|
BSX
Boston Scientific
|
◎ Target | Richard Newitter ★★★★☆ #460 | Buy | $62.00→ $57.00-8.1% |
|
Jul 30
15:42 UTC
|
ARM
ARM
|
◎ Target | Joe Quatrochi not yet tracked | Overweight | $350.00→ $280.00-20.0% |
|
Jul 30
15:42 UTC
|
ARCC
Ares Capital
|
◎ Target | Arren Cyganovich ★★★★☆ #675 | Buy | $22.00→ $21.00-4.5% |
|
Jul 30
15:42 UTC
|
APH
Amphenol
|
◎ Target | William Stein ★★☆☆☆ #2647 | Buy | $200.00→ $215.00+7.5% |
|
Jul 30
15:42 UTC
|
AER
Aercap
|
◎ Target | Arren Cyganovich ★★★★☆ #675 | Buy | $175.00→ $180.00+2.9% |
|
Jul 30
15:42 UTC
|
ADPT
Adaptive Biotechnologies
|
◎ Target | Dan Brennan not yet tracked | Buy | $25.00→ $28.00+12.0% |
|
Jul 30
15:42 UTC
|
ADP
Automatic Data Processing
|
◎ Target | Jason Kupferberg ★★★★☆ #868 | Equal Weight | $248.00→ $283.00+14.1% |
|
Jul 30
15:42 UTC
|
SMTI
Sanara MedTech
|
↓ Downgrade | Frank Takkinen ★★☆☆☆ #2704 | Buy→ Hold | $35.00 |
|
Jul 30
15:42 UTC
|
NBTB
NBT Bancorp
|
↓ Downgrade | Matthew Breese ★★★☆☆ #1044 | Overweight→ Equal Weight | $52.00→ $55.00+5.8% |
|
Jul 30
15:42 UTC
|
HUM
Humana
|
↓ Downgrade | firm only | Hold | |
|
Jul 30
15:42 UTC
|
HUM
Humana
|
↑ Upgrade | Jessica Tassan ★★★★☆ #658 | Neutral→ Overweight | |
|
Jul 30
15:42 UTC
|
HUM
Humana
|
↑ Upgrade | firm only | Peer Perform→ Outperform | |
|
Jul 30
15:42 UTC
|
ARM
ARM
|
↑ Upgrade | Pierre Ferragu ★★★★★ #53 | Neutral→ Buy | $260.00 |
|
Jul 30
15:42 UTC
|
AAUC
Allied Gold
|
↑ Upgrade | firm only | Outperform | |
|
Jul 30
14:42 UTC
|
WAY
Waystar
|
◎ Target | Stan Berenshteyn ★★★★★ #317 | Overweight | $36.00→ $33.00-8.3% |
|
Jul 30
14:42 UTC
|
TGT
Target
|
◎ Target | Edward Kelly ★★★☆☆ #1110 | Overweight | $140.00→ $165.00+17.9% |
|
Jul 30
14:42 UTC
|
SOFI
SoFi Technologies
|
◎ Target | Donald Fandetti ★★★☆☆ #1804 | Equal Weight | $18.00→ $17.00-5.6% |
|
Jul 30
14:42 UTC
|
RGEN
Repligen
|
◎ Target | Evan Stampler not yet tracked | Overweight | $180.00→ $185.00+2.8% |
|
Jul 30
14:42 UTC
|
QURE
uniQure
|
◎ Target | Yanan Zhu ★★☆☆☆ #2604 | Overweight | $60.00→ $75.00+25.0% |
|
Jul 30
14:42 UTC
|
PFSI
PennyMac Financial Services
|
◎ Target | Donald Fandetti ★★★☆☆ #1804 | Overweight | $100.00→ $95.00-5.0% |
|
Jul 30
14:42 UTC
|
OMF
OneMain
|
◎ Target | David M. Scharf not yet tracked | Market Outperform | $68.00→ $70.00+2.9% |
|
Jul 30
14:42 UTC
|
META
Meta Platforms
|
◎ Target | Scott Devitt ★★☆☆☆ #2747 | Neutral | $671.00→ $595.00-11.3% |
|
Jul 30
14:42 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Yanan Zhu ★★☆☆☆ #2604 | Overweight | $100.00→ $95.00-5.0% |
|
Jul 30
14:42 UTC
|
IART
Integra LifeSciences
|
◎ Target | Larry Biegelsen ★★★★☆ #858 | Equal Weight | $15.00→ $18.00+20.0% |
|
Jul 30
14:42 UTC
|
HUM
Humana
|
◎ Target | Jason Cassorla ★★★★☆ #441 | Buy | $269.00→ $471.00+75.1% |
|
Jul 30
14:42 UTC
|
GEHC
GE HealthCare Technologies
|
◎ Target | Larry Biegelsen ★★★★☆ #858 | Overweight | $75.00→ $85.00+13.3% |
|
Jul 30
14:42 UTC
|
ECL
Ecolab
|
◎ Target | Jason Haas not yet tracked | Equal Weight | $275.00→ $295.00+7.3% |
|
Jul 30
14:42 UTC
|
DMRA
Damora Therapeutics, Inc. Common Stock
|
◎ Target | David Nierengarten ★★☆☆☆ #2467 | Outperform | $35.00→ $40.00+14.3% |
|
Jul 30
14:42 UTC
|
CVNA
Carvana
|
◎ Target | Andrew Boone ★☆☆☆☆ #2924 | Market Outperform | $103.00→ $83.00-19.4% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.